• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Quantum-Si Incorporated

    3/3/25 4:51:03 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials
    Get the next $QSI alert in real time by email
    S-8 1 ef20044716_s8.htm S-8
    As filed with the Securities and Exchange Commission on March 3, 2025

    Registration No. 333-


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549



    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933



    Quantum-Si Incorporated
    (Exact name of registrant as specified in its charter)


    Delaware
     
    85-1388175
    (State or other jurisdiction of incorporation or organization)
     
    (I.R.S. Employer Identification No.)

    29 Business Park Drive
    Branford, Connecticut
     
    06405
    (Address of Principal Executive Offices)
     
    (Zip Code)

    2021 Equity Incentive Plan
    2023 Inducement Equity Incentive Plan, as amended
    (Full title of the plan)

    Jeffrey Hawkins
    Chief Executive Officer
    Quantum-Si Incorporated
    29 Business Park Drive
    Branford, Connecticut 06405
    (Name and address of agent for service)

    (866) 688‑7374
    (Telephone number, including area code, of agent for service)



    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

    Large accelerated filer ☐
    Accelerated filer ☐
    Non-accelerated filer ☒
    Smaller reporting company ☒
     
    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐



    EXPLANATORY NOTE

    This registration statement on Form S-8 (this “Registration Statement”) is being filed by Quantum-Si Incorporated (the “Registrant”) for the purpose of registering an aggregate of 9,675,630 shares of Class A common stock, par value $0.0001 per share (“Class A Common Stock”), consisting of:
     

    i.
    6,675,630 additional shares of Class A Common Stock reserved under the Quantum-Si Incorporated 2021 Equity Incentive Plan (the “2021 Plan”), representing an increase of 6,675,630 shares reserved under the 2021 Plan effective January 1, 2025 by operation of the 2021 Plan’s “evergreen” provision; and
     

    ii.
    3,000,000 additional shares of Class A Common Stock reserved under the Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the “2023 Plan”).
     
    These additional shares of Class A Common Stock are securities of the same class as other securities for which registration statements on Form S-8 relating to the same benefit plans were filed with the Securities and Exchange Commission (the “Commission”) on September 2, 2021 (File No. 333-259271), March 1, 2022 (File No. 333-263154), March 17, 2023 (File No. 333-270630), July 20, 2023 (File No. 333-273350) and February 29, 2024 (File No. 333-277533) (collectively, the “Prior Registration Statements”).
     
    The contents of the Prior Registration Statements are hereby incorporated by reference in this Registration Statement pursuant to General Instruction E to Form S-8, except as otherwise set forth herein.

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3.
    Incorporation of Documents by Reference.

    The following documents filed by the Registrant with the Commission pursuant to the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are incorporated herein by reference:


    a.
    The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Annual Report”), filed with the Commission on March 3, 2025.
     

    b.
    Any other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the registrant document referred to in (a) above.
     

    c.
    The description of the Registrant’s securities contained in the Registrant’s registration statement on Form 8-A (File No. 001-39486), filed by the Registrant with the Commission under Section 12(b) of the Exchange Act, on September 2, 2020, including any amendments or reports filed for the purpose of updating such description.
     
    In addition, all documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and made part hereof from their respective dates of filing (such documents, and the documents listed above, being hereinafter referred to as “Incorporated Document(s)”); provided, however, that the documents listed above or subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act in each year during which the offering made by this Registration Statement is in effect prior to the filing with the Commission of the Registrant’s Annual Report on Form 10-K covering such year shall cease to be Incorporated Documents or be incorporated by reference in this Registration Statement from and after the filing of such Annual Report.


    Any statement contained in an Incorporated Document shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed Incorporated Document modifies or supersedes such statement. Any statement contained herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed Incorporated Document modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    Item 6.
    Indemnification of Directors and Officers.

    Section 145 of the Delaware General Corporation Law (the “DGCL”), permits a corporation to indemnify its directors and officers against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlements actually and reasonably incurred by them in connection with any action, suit or proceeding brought by third parties. The directors or officers must have acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reason to believe their conduct was unlawful. In a derivative action, an action only by or in the right of the corporation, indemnification may be made only for expenses, including attorney’s fees, actually and reasonably incurred by directors and officers in connection with the defense or settlement of an action or suit, and only with respect to a matter as to which they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation. No indemnification shall be made if such person shall have been adjudged to be liable to the corporation, unless and only to the extent that the court in which the action or suit was brought determines upon application that the defendant officers or directors are fairly and reasonably entitled to indemnity for such expenses despite such adjudication of liability. The amended and restated certificate of incorporation, as amended, of the registrant provides that the registrant may indemnify its directors, officers, employees or agents to the fullest extent permitted by applicable law and the amended and restated bylaws of the registrant provide that the registrant shall indemnify its directors and officers to the fullest extent permitted by applicable law.

    Section 102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director or officer of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except for liability of (1) a director or officer for any breach of the director’s or officer’s duty of loyalty to the corporation or its stockholders, (2) a director or officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3) a director for payments of unlawful dividends or unlawful stock purchases or redemptions, (4) a director or officer for any transaction from which the director or officer derived an improper personal benefit, or (5) an officer in any action by or in the right of the corporation. The amended and restated certificate of incorporation, as amended, of the registrant provides for such limitation of liability with respect to directors and officers of the corporation.

    We have entered into indemnification agreements with each of our directors and officers in which we have agreed to indemnify and hold harmless, and also advance expenses as incurred, to the fullest extent permitted under applicable law, against all expenses, losses and liabilities incurred by the indemnitee or on the indemnitee’s behalf arising from the fact that such person is or was a director, officer, employee or agent of our company or our subsidiaries.


    The indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter acquire under any statute, our amended and restated certificate of incorporation, as amended, our amended and restated bylaws, any agreement, any vote of stockholders or disinterested directors or otherwise.

    We maintain standard policies of insurance that provide coverage (1) to our directors and officers against loss rising from claims made by reason of breach of duty or other wrongful act and (2) to us with respect to indemnification payments that we may make to such directors and officers.

    Item 8.
    Exhibits.


    Exhibit
    Number
     
    Exhibit Description
    Filed
    Herewith
    Incorporated
    by Reference
    herein from
    Form or
    Schedule
    Filing Date
    SEC File/
    Reg. Number
    4.1
     
    Second Amended and Restated Certificate of Incorporation of the Registrant, as amended.
     
    10-Q
    (Exhibit 3.1)
    8/7/2024
    001-39486
                 
    4.2
     
    Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation, as amended, of the Registrant.
     
    8-K
    (Exhibit 3.1)
    5/17/2024
    001-39486
                 
    4.3
     
    Amended and Restated Bylaws of the Registrant.
     
    10-K
    (Exhibit 3.2)
    3/1/2022
    001-39486
                 
    4.4
     
    Specimen Class A Common Stock Certificate.
     
    S-4/A
    (Exhibit 4.1)
    5/11/2021
    333-253691
                 
    4.5
     
    Warrant Agreement, dated September 3, 2020, by and between the Registrant and Continental Stock Transfer & Trust Company.
     
    8-K
    (Exhibit 4.1)
    9/9/2020
    001-39486
                 
    5.1
     
    Opinion of DLA Piper LLP (US)
    X
         
                 
    23.1
     
    Consent of DLA Piper LLP (US) (included in opinion of counsel filed as Exhibit 5.1).
    X
         
                 
    23.2
     
    Consent of PricewaterhouseCoopers LLP.
    X
         
                 
    23.3
     
    Consent of Deloitte & Touche LLP.
    X
         
                 
    24.1
     
    Power of Attorney (included on the signature page hereof).
    X
         
                 
    99.1+
     
    Quantum-Si Incorporated 2021 Equity Incentive Plan.
     
    8-K
    (Exhibit 10.13.1)
    6/15/2021
    001-39486
                 
    99.2+
     
    Form of Stock Option Agreement under 2021 Equity Incentive Plan.
     
    8-K
    (Exhibit 10.13.2)
    6/15/2021
    001-39486
                 
    99.3+
     
    Form of Restricted Stock Unit Agreement under 2021 Equity Incentive Plan.
     
    Form 10-K
    (Exhibit 10.13.3)
    2/29/2024
    001-39486
                 
    99.4+
     
    2023 Inducement Equity Incentive Plan, as amended.
     
    Form 10-Q
    (Exhibit 10.3)
    11/12/2024
    001-39486
                 
    99.5+
     
    Form of Stock Option Agreement under the 2023 Inducement Equity Incentive Plan.
     
    Form S-8
    (Exhibit 99.2)
    7/20/2023
    333-273350
                 
    99.6+
     
    Form of Restricted Stock Agreement under the 2023 Inducement Equity Incentive Plan.
     
    Form 10-Q
    (Exhibit 10.3.1)
    11/12/2024
    001-39486
                 
    107
     
    Filing Fee Table
    X
         

    + Denotes management contract or compensatory plan or arrangement


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Branford, State of Connecticut, on March 3, 2025.

     
    QUANTUM-SI INCORPORATED
     
    By:
    /s/ Jeffrey Hawkins
       
    Jeffrey Hawkins
       
    President and Chief Executive Officer

    POWER OF ATTORNEY AND SIGNATURES

    Each person whose signature appears below constitutes and appoints each of Jeffrey Hawkins and Jeffry Keyes, acting alone or together with another attorney-in-fact, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for such person and in his or her name, place and stead, in any and all capacities, to sign any or all further amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.


    Signature
     
    Title
     
    Date
             
    /s/ Jeffrey Hawkins
     
    President, Chief Executive Officer and Director
    (Principal Executive Officer)
     
    March 3, 2025
    Jeffrey Hawkins
             
    /s/ Jeffry Keyes
     
    Chief Financial Officer and Treasurer
    (Principal Financial and Accounting Officer)
     
    March 3, 2025
    Jeffry Keyes
             
    /s/ Charles Kummeth
     
    Chairman of the Board
     
    March 3, 2025
    Charles Kummeth
           
             
    /s/ Jonathan M. Rothberg, Ph.D.
     
    Director
     
    March 3, 2025
    Jonathan M. Rothberg, Ph.D.
             
    /s/ Scott Mendel
     
    Director
     
    March 3, 2025
    Scott Mendel
             
    /s/ John Patrick Kenny
     
    Director
     
    March 3, 2025
    John Patrick Kenny
             
    /s/ Ruth Fattori
     
    Director
     
    March 3, 2025
    Ruth Fattori
             
    /s/ Brigid A. Makes
     
    Director
     
    March 3, 2025
    Brigid A. Makes
             
    /s/ Kevin Rakin
     
    Director
     
    March 3, 2025
    Kevin Rakin
             
    /s/ Amir Jafri
     
    Director
     
    March 3, 2025
    Amir Jafri
           
             
    /s/ Paula Dowdy
     
    Director
     
    March 3, 2025
    Paula Dowdy
           



    Get the next $QSI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $QSI

    DatePrice TargetRatingAnalyst
    2/7/2025$3.75Buy
    Alliance Global Partners
    12/8/2023$3.00Buy
    H.C. Wainwright
    9/25/2023$3.50 → $2.00Buy → Hold
    Canaccord Genuity
    10/20/2021$13.00Buy
    Canaccord Genuity
    More analyst ratings

    $QSI
    Leadership Updates

    Live Leadership Updates

    See more
    • Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the appointment of Charles ("Chuck") Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During Mr. Kummeth's tenure at Bio-Techne, he oversaw tremendous growth across all aspects of the business including annual revenue growth from $300M to over $1.1B, growth in the employee base from 800 to over 3,000, and the successful execution of 19 acquisitions, all while maintaining a 35% or better EBITDA level. Under Mr. Ku

      5/30/24 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321183506/en/Paula Dowdy (Photo: Business Wire) Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a world leading lab automation tools company based in the UK and is an advisor at EQT Life Sciences, one of Europe's leading investors targeting innovative

      3/21/24 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Introduces World's First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company's protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer and distributor with a rich history dating back to the 1950s, will distribute Quantum-Si's next-generation protein sequencer™ and associated consumables throughout Japan. "Working with Quantum-Si marks a pivotal moment for TOMY Digital Biology, aligning with our commitment to advancing life sciences. We're poised to empower Japanese researchers wit

      1/18/24 8:30:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    $QSI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, announces participation in an expert panel during the upcoming GenomeWeb-hosted webinar, "From Raw to Reusable: Considerations for Data Integration and Real-World Standardization in Proteomics." When: June 20, 2025, at 8 a.m. PDT/11 a.m. EDT This one-hour webinar will explore critical strategies for improving the accessibility, integration, and standardization of data across proteomics platforms. Attendees will learn how to deposit data into public repositories, apply metadata annotation best practices, normalize cros

      6/19/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, announces a featured talk at the upcoming Festival of Genomics & Biodata Boson, highlighting innovative advances in protein sequencing technology for drug development. Melissa Deck, Director of Platform at Liberate Bio, will present "Precision Proteomics: Advancing Drug Development with Next-Gen Protein Sequencing™ (NGPS™)," showcasing how Quantum-Si's Platinum® Pro instrument is transforming the way scientists study proteins. Session Highlights Include: Introduction to single-molecule protein sequencing with NGPS™

      6/17/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si's Board of Directors has granted 45,529 restricted stock units ("RSUs") to new employees under the Company's previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the "2023 Inducement Plan"). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4). The 2023 Inducement Plan is used exclusively for the grant of equity awards

      6/13/25 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    $QSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Makes Brigid

      4 - Quantum-Si Inc (0001816431) (Issuer)

      5/21/25 4:01:33 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form 4 filed by Director Kenny John P.

      4 - Quantum-Si Inc (0001816431) (Issuer)

      5/21/25 4:01:36 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form 4 filed by Director Kummeth Charles R.

      4 - Quantum-Si Inc (0001816431) (Issuer)

      5/21/25 4:01:35 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    $QSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alliance Global Partners initiated coverage on Quantum-Si with a new price target

      Alliance Global Partners initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.75

      2/7/25 8:29:38 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • H.C. Wainwright initiated coverage on Quantum-Si with a new price target

      H.C. Wainwright initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.00

      12/8/23 7:55:31 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si downgraded by Canaccord Genuity with a new price target

      Canaccord Genuity downgraded Quantum-Si from Buy to Hold and set a new price target of $2.00 from $3.50 previously

      9/25/23 9:04:14 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    $QSI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Keyes Jeffry R. bought $43,465 worth of shares (50,000 units at $0.87), increasing direct ownership by 13% to 446,820 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      8/13/24 6:01:25 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • President & CEO Hawkins Jeffrey Alan bought $21,272 worth of shares (25,000 units at $0.85), increasing direct ownership by 3% to 1,003,757 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      8/13/24 6:01:28 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Director Kummeth Charles R. bought $148,459 worth of shares (170,000 units at $0.87), increasing direct ownership by 92% to 355,000 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      8/13/24 6:01:24 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    $QSI
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Quantum-Si Incorporated

      SCHEDULE 13G/A - Quantum-Si Inc (0001816431) (Subject)

      6/6/25 2:58:53 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SD filed by Quantum-Si Incorporated

      SD - Quantum-Si Inc (0001816431) (Filer)

      5/22/25 4:05:35 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Quantum-Si Inc (0001816431) (Filer)

      5/19/25 4:05:24 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    $QSI
    Financials

    Live finance-specific insights

    See more
    • Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2025 on Thursday, May 15, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personali

      4/24/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results

      Achieves First Quarterly Revenue Over $1 Million Completes Capital Raises of $86 Million Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the fourth quarter and full year ended December 31, 2024. Press Release Highlights Reported revenue of $1.2 million for the fourth quarter of 2024 and $3.1 million for the full year 2024 (representing a 183% full year-over-year growth) Raised capital of over $86 million between the fourth quarter of 2024 and first week of 2025 (extending cash runway into the second half of 2027) Announced the launch of Platinum® Pro in January 2025, with shipp

      3/3/25 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 3, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in numbe

      2/12/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    $QSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Quantum-Si Incorporated

      SC 13D/A - Quantum-Si Inc (0001816431) (Subject)

      9/17/24 4:24:56 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Quantum-Si Incorporated

      SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

      6/28/24 5:16:32 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G filed by Quantum-Si Incorporated

      SC 13G - Quantum-Si Inc (0001816431) (Subject)

      2/13/24 9:41:18 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials